Christopher Hauke

Head Of Strategic IP & Innovation at SCHOTT Pharma

Christopher Hauke has a diverse work experience spanning from 2003 to the present. Christopher currently works as the Head of Strategic IP & Innovation at SCHOTT Pharma, a position they have held since 2022. Prior to this, they worked at SCHOTT from 2018 to 2022, where they served as the Head of Strategic IP and Innovation, Pharma, as well as the Senior Manager Strategic IP.

Before joining SCHOTT, Christopher worked at Fresenius Medical Care AG & Co. KGaA from 2014 to 2018, holding the position of Manager IP Strategy & Projects and Junior Manager Global Patent Strategy.

Christopher'searlier experiences include working as a Postdoc and PhD student at Johannes Gutenberg Universität Mainz from 2010 to 2013, and as a Member of the Graduate School Materials Science in Mainz from 2011 to 2013.

Additionally, Christopher gained experience as a Student Research Assistant at the University of Mainz from 2006 to 2009, a Working Student at Institut Laue Langevin in 2006, and as a Civil Service employee at the Museum of Natural History from 2003 to 2004.

Christopher Hauke holds an Executive MBA from Quantic School of Business and Technology, which they obtained between 2021 and 2022. Christopher also holds a PhD in Physical Chemistry from Johannes Gutenberg University Mainz, which they obtained from 2010 to 2013. Christopher has a Bachelor's degree in Physics, equivalent to a Master's, also from Johannes Gutenberg University Mainz, which they obtained from 2004 to 2009. Christopher pursued Engineering Physics at KTH Royal Institute of Technology from 2007 to 2008. Christopher completed their high school education at Willigis Gymnasium Mainz, receiving an Abitur (High School Diploma) in 2003 with a focus on Physics, Mathematics, and French. Additionally, Christopher has obtained several certifications including an Executive Master of Business Administration from Quantic School of Business and Technology in 2022, a Certified Competitive Intelligence Professional "Master of CI" (CIP-II) from the Academy of Competitive Intelligence in 2020, a Certified Competitive Intelligence Professional (CIP™-I) from the Academy of Competitive Intelligence LLC in 2019, and a Qualified Negotiator® certification from the Schranner Negotiation Institute in 2017.

Links

Previous companies

SCHOTT logo
Fresenius Medical Care HIMG Dialysis Center logo

Timeline

  • Head Of Strategic IP & Innovation

    August, 2022 - present